These results suggested that the increase in CD3+CD8+ T cells and decrease in CD3+CD4+ T cells and MDSC in vivo might be involved in the antitumoral response of T. gondii infection in the mouse model of CRC. The gene discussed is CD4; the disease is colorectal carcinoma.